Literature DB >> 6614234

Naloxone administration in obsessive-compulsive disorder: report of two cases.

T R Insel, D Pickar.   

Abstract

Two patients with obsessive-compulsive disorder experienced an exacerbation of chronic obsessional doubt after double-blind, placebo-controlled administration of naloxone. Endogenous opiates may be involved in the pathogenesis of this symptom.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6614234     DOI： 10.1176/ajp.140.9.1219

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  10 in total

Review 1.  Introduction to behavioral addictions.

Authors:  Jon E Grant; Marc N Potenza; Aviv Weinstein; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2010-09       Impact factor: 3.829

Review 2.  Pharmacological treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Michael H Bloch
Journal:  Psychiatr Clin North Am       Date:  2014-07-24

Review 3.  Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.

Authors:  Leonardo F Fontenelle; Sanne Oostermeijer; Ben J Harrison; Christos Pantelis; Murat Yücel
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 4.  Compulsive features in behavioural addictions: the case of pathological gambling.

Authors:  Nady el-Guebaly; Tanya Mudry; Joseph Zohar; Hermano Tavares; Marc N Potenza
Journal:  Addiction       Date:  2011-10-10       Impact factor: 6.526

5.  Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

Authors:  M Olga Rojas-Corrales; Juan Gibert-Rahola; Juan A Mico
Journal:  Psychopharmacology (Berl)       Date:  2006-11-11       Impact factor: 4.530

Review 6.  Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review.

Authors:  Naomi A Fineberg; Marc N Potenza; Samuel R Chamberlain; Heather A Berlin; Lara Menzies; Antoine Bechara; Barbara J Sahakian; Trevor W Robbins; Edward T Bullmore; Eric Hollander
Journal:  Neuropsychopharmacology       Date:  2009-11-25       Impact factor: 7.853

Review 7.  The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions.

Authors:  Marc Nicholas Potenza; Lorrin Michael Koran; Stefano Pallanti
Journal:  Psychiatry Res       Date:  2009-10-06       Impact factor: 3.222

8.  Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder.

Authors:  Malcolm B Liddell; Victor Aziz; Patrick Briggs; Nimalee Kanakkehewa; Omar Rawi
Journal:  Ther Adv Psychopharmacol       Date:  2013-02

Review 9.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 10.  The Role of Social Stress in the Development of Inhibitory Control Deficit: A Systematic Review in Preclinical Models.

Authors:  Lucía Sánchez-Salvador; Ángeles Prados-Pardo; Elena Martín-González; Manuela Olmedo-Córdoba; Santiago Mora; Margarita Moreno
Journal:  Int J Environ Res Public Health       Date:  2021-05-06       Impact factor: 3.390
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.